As Wall Street returns back to work, these S&P 500 stocks were busy all summer making big returns in investors' portfolios.» Read More
Some of Wednesday's midday movers:
Art Cashin of UBS Financial Services tells CNBC's Mary Thompson why the S&P could fall all the way back to 1840.
New homes sales came in disappointingly low, leading to serious questions about U.S. economic strength. But the market doesn't seem to care.
There may be opportunity in this tech name, but you have to be nimble.
The coffee company is in advanced talks to acquire nearly 10 percent of soft-drink maker SodaStream, according to Israeli business newspaper Globes.
Bankrate looks at seven retirement issues that you might be stewing about that don't matter, at least not as much as these much more troubling issues.
Apple in the news after the bell Wednesday:
Stocks of SunEdison and Conn's jumped Tuesday on news that David Einhorn's Greenlight Capital had opened new positions in them.
Jim Cramer believes that there are new realities at play deep inside the market. Have you gotten a handle on them?
The weather phenomenon is likely to return, possibly bringing enough water to end the severe drought in California.
Bonds are pretty clearly a bad job, with returns relatively meager and prices set to fall, but yield-seeking investors keep pushing money their way.
Investors need to get bullish on the aerospace industry as "the strongest part of the world economy," CNBC's Jim Cramer says.
Considering Cramer is a big fan of M&A, why is he so opposed to the Allergan takeover?
Some of the names on the move ahead of the open.
The "Fast Money" traders share their final trades of the day.
After an early April swoon, most stocks have recovered. However, there are still 8 of them that are down 10 percent or more. Investors are suffering.
Are companies misleading investors on the way they report earnings? Renowned value investor Bob Olstein thinks so.
Looking at the modest gains in the Dow and S&P, you wouldn’t think anything big happened in the market. But it did.
Stocks are in the midst of one of the strongest rallies in months, but not everyone is taking part.
One astute trader picked up big money overnight by buying options in Furiex Pharmaceuticals.
Get the best of CNBC in your inbox